Evidence map›Paper›PMID 39724488›Full record

ReviewImmunological reviews2025

The Integrin Receptors: From Discovery to Structure to Medicines.

M Amin Arnaout

Erratum issuedAbstract readReview
In one paragraph

Review in Immunological reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Integrin-Alpha-6+ Cells Are Responsible for Blastema Formation During Oral Siphon Regeneration in Ciona robusta.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  3. INTEGRIN FUNCTION IN LEUKOCYTE-MEDIATED INFLAMMATION-ACTINOPATHIES IN IMMUNE DISEASES.Transactions of the American Clinical and Climatological Association · 2025
    Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

M Amin ArnaoutMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-8270-0371

Funding

Structure and Function of beta2 IntegrinR01DK048549 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ARNAOUT, M. AMIN · 1994 to 2016
$6.0M
Transcriptional regulation of beta2 integrinsP01DK050305 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ARNAOUT, M. AMIN · 1995 to 2004
$5.8M
Structure and Function of Integrins in the KidneyR01DK088327 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ARNAOUT, M. AMIN · 2010 to 2025
$5.3M
Targeting innate immunity for induction of robust renal allograft toleranceU01AI174968 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI M. AMIN ARNAOUT, TATSUO KAWAI · 2023 to 2026
$4.3M
Platelet alphaIIbbeta3 activation and its therapeutic targetingR01HL141366 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BRIAN D ADAIR, M. AMIN ARNAOUT · 2019 to 2026
$3.6M
Structure-function of the Proangiogenic Integrin alphaVbR01HL070219 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ARNAOUT, M. AMIN · 2002 to 2006
$2.2M
The Phagocyte MembraneR01DK074447 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI ARNAOUT, M. AMIN · 2005 to 2009
$2.1M
Effects of combining anti-CD40 and anti-CD11b mAb107 on survival of pig kidney xenografts in cynomolgus monkeysR21AI168393 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ARNAOUT, M. AMIN · 2022 to 2023
$447k
Role of integrin CD11b in delayed graft function and allorejectionR21AI146871 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ARNAOUT, M. AMIN, COSIMI, A BENEDICT · 2019 to 2020
$445k
American Heart AssociationNational Institute of Allergy and Infectious Diseases AI146871National Institute of Allergy and Infectious Diseases AI168393NHLBI NIH HHS HL141366NHLBI NIH HHS R01 HL070219NHLBI NIH HHS R01 HL141366NIAID NIH HHS R21 AI146871NIAID NIH HHS R21 AI168393NIAID NIH HHS U01 AI174968NIDDK NIH HHS DK048549NIDDK NIH HHS DK088327NIDDK NIH HHS P01 DK050305NIDDK NIH HHS R01 DK048549NIDDK NIH HHS R01 DK074447NIDDK NIH HHS R01 DK088327
6 · The paper itself

Abstract

Innate immune cells perform vital tasks in detecting, seeking, and eliminating invading pathogens, thus ensuring host survival. However, loss of function of these cells or their overactive response to tissue injury often causes serious ailments. It is, therefore, crucial to understand at a basic level how these cells function in health and disease. A major step toward this goal came from studies I conducted in the late 1970s investigating the cause of life-threatening bacterial infections in a pediatric patient. This work led us to trace this disease to the inability of the patient's neutrophils to seek and clear infections due to an inherited deficiency in leukocyte adhesion caused by the loss of a plasma membrane glycoprotein complex now known as CD11/CD18 or β2 integrins. I followed this work by determining the 3-dimensional structures of integrins. These studies provided the foundation for understanding the unique properties of integrins in mediating bidirectional cell adhesion signaling and enabled a structure-guided design of compounds to dial down overactive integrins in common disorders, including thromboinflammatory and autoimmune diseases.

Indexed as

IntegrinsNeutrophilsAnimalsCell AdhesionHumansImmunity, InnateSignal TransductionIntegrinscell adhesionintegrinsphagocytosisstructural biology

Identifiers

PMID39724488
PMCPMC11752789

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.